The role of the insulin-like growth factor 1 receptor axis in multiple myeloma

IL-21 Stimulates Human Myeloma Cell Growth through an Autocrine IGF-1 Loop

(2014) E. Menoret et al.   JOURNAL OF IMMUNOLOGY

Multiple Myeloma and Immunosecretory Disorders

(2008) Saad P. Shaheen et al.   ADVANCES IN ANATOMIC PATHOLOGY

The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cells

(2008) Patricia Maiso et al.   BRITISH JOURNAL OF HAEMATOLOGY

AID-Dependent Activation of a MYC Transgene Induces Multiple Myeloma in a Conditional Mouse Model of Post-Germinal Center Malignancies

(2008) Marta Chesi et al.   CANCER CELL

An Update on the Xenograft and Mouse Models Suitable for Investigating New Therapeutic Compounds for the Treatment of B-Cell Malignancies

(2008) Paolo Macor et al.   CURRENT PHARMACEUTICAL DESIGN

Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agents

(2008) M. Teresa Cibeira et al.   CYTOKINE

Hepatocyte growth factor promotes migration of human myeloma cells

(2008) R. U. Holt et al.   HAEMATOLOGICA

Phase I, Pharmacokinetic and Pharmacodynamic Study of the Anti–Insulinlike Growth Factor Type 1 Receptor Monoclonal Antibody CP-751,871 in Patients With Multiple Myeloma

(2008) Martha Q. Lacy et al.   JOURNAL OF CLINICAL ONCOLOGY

Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: Lessons from the first clinical trials

(2008) J. Rodon et al.   MOLECULAR CANCER THERAPEUTICS

The role of insulin receptors and IGF-I receptors in cancer and other diseases

(2008) Francesco Frasca et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY